China East Education Holdings Limited (0667.HK)
Hefei, CN
As an investment holding company, China East Education Holdings Limited specializes in delivering vocational education and training. Its educational offerings span diverse fields including culinary arts, information and internet technology, automotive services, and fashion and beauty. By the end of 2021 (December 31st), the company managed an extensive network of 231 educational institutions. This network comprised 72 New East Culinary Education centers focused on Chinese cooking traditions and practices; 45 Omick Education of Western Cuisine and Pastry centers, providing instruction in Western culinary arts such as baking, desserts, international cuisines, bartending, and barista skills; 33 Xinhua Internet Technology Education facilities; 22 Wisezone Data Technology Education centers delivering information and internet technology curricula specifically for junior college and university students; 38 Wontone Automotive Education centers, offering practical training in auto repair and various other automotive services, including vehicle commerce; a single On-mind Fashion & Beauty Education center dedicated to fostering skills for professionals in the fashion and beauty industries; and 20 Cuisine Academy branded centers, which offer bespoke catering experiences across Mainland China and Hong Kong. Beyond its core vocational schools, the company also offers data technology educational services and is involved in technology development, consulting, and promotional activities. Established in 1988, China East Education Holdings Limited maintains its headquarters in Hefei, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.83% | -4.61% | -10.02% | -26.77% | -24.68% | -28.31% | -24.32% | +44.68% | -71.90% | -52.02% | -52.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 8 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Education & Training Services: +8.8%+12.1% ★ Q4'25: +19.9% (vs Q4'23)
-
EPS growth Education & Training Services: +23.7%+47.8% ★ Q4'25: +409.6% (vs Q4'23)
-
FCF margin FCF growth · Education & Training Services: +33.4%+16.8% ★ Q4'25: +20.8% (vs Q4'23)
-
EBIT margin Education & Training Services: +14.0%+21.2% ★ Q4'25: +18.8% (vs Q4'23)
-
ROIC Education & Training Services: +8.8%+20.1% ★ Q4'25: +38.5% (vs Q4'23)
-
Share dilution Education & Training Services: +0.0%+2.4% Q4'25: +2.6% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Education & Training Services: -0.27×1.14× ★ Q4'25: 0.59× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 12 Rev. Ana. 7 EPS Ana. |
Dec 2027 12 Rev. Ana. 7 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.91B
est: 4.59B (-14.8%)
|
3.65B
est: 4.33B (-15.7%)
|
4.14B
est: 5.02B (-17.5%)
|
3.82B
est: 4.34B (-12.1%)
|
3.98B
est: 4.77B (-16.6%)
|
4.12B
est: 4.08B (+0.9%)
|
4.62B
est: 4.57B (+1.1%)
|
5.33B
5.14B – 5.56B
+16.8% YoY
|
5.90B
5.23B – 6.31B
+10.5% YoY
|
6.53B
6.03B – 6.90B
+10.8% YoY
|
| EBITDA |
1.52B
est: 937.11M (+62.0%)
|
850.13M
est: 884.41M (-3.9%)
|
864.87M
est: 1.03B (-15.7%)
|
730.52M
est: 887.71M (-17.7%)
|
641.19M
est: 975.41M (-34.3%)
|
936.77M
est: 874.78M (+7.1%)
|
1.31B
est: 979.63M (+33.7%)
|
1.14B
1.10B – 1.19B
+16.8% YoY
|
1.26B
1.12B – 1.35B
+10.5% YoY
|
1.40B
1.29B – 1.48B
+10.8% YoY
|
| EBIT |
975.04M
est: 566.10M (+72.2%)
|
526.27M
est: 534.27M (-1.5%)
|
551.34M
est: 619.68M (-11.0%)
|
411.04M
est: 536.26M (-23.4%)
|
324.70M
est: 589.24M (-44.9%)
|
620.27M
est: 558.72M (+11.0%)
|
978.63M
est: 625.69M (+56.4%)
|
730.98M
704.11M – 761.53M
+16.8% YoY
|
807.81M
716.57M – 864.93M
+10.5% YoY
|
895.13M
826.47M – 946.12M
+10.8% YoY
|
| Net Income |
847.82M
est: 717.83M (+18.1%)
|
257.61M
est: 369.05M (-30.2%)
|
302.17M
est: 399.92M (-24.4%)
|
367.53M
est: 288.81M (+27.3%)
|
272.62M
est: 435.88M (-37.5%)
|
512.60M
est: 492.10M (+4.2%)
|
756.09M
est: 813.60M (-7.1%)
|
1.04B
942.75M – 1.11B
+27.8% YoY
|
1.24B
1.09B – 1.38B
+19.7% YoY
|
1.46B
1.32B – 1.57B
+17.6% YoY
|
| SGA |
1.27B
est: 1.73B (-26.4%)
|
1.40B
est: 1.63B (-14.4%)
|
1.53B
est: 1.90B (-19.3%)
|
1.46B
est: 1.64B (-11.1%)
|
1.57B
est: 1.80B (-13.1%)
|
1.48B
est: 1.50B (-1.4%)
|
1.56B
est: 1.68B (-7.3%)
|
1.97B
1.89B – 2.05B
+16.8% YoY
|
2.17B
1.93B – 2.33B
+10.5% YoY
|
2.41B
2.22B – 2.55B
+10.8% YoY
|
| EPS |
0.43
est: 0.33 (+30.9%)
|
0.12
est: 0.17 (-29.0%)
|
0.14
est: 0.18 (-23.5%)
|
0.17
est: 0.13 (+28.6%)
|
0.12
est: 0.20 (-39.9%)
|
0.24
est: 0.22 (+9.1%)
|
0.34
est: 0.36 (-6.5%)
|
0.46
0.42 – 0.50
+27.8% YoY
|
0.56
0.49 – 0.62
+19.7% YoY
|
0.65
0.59 – 0.70
+17.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI China Small-Cap ETF ECNS | 0.19% | 122.8K | 0.59% |
| 2 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.09% | 39.0K | 0.54% |
| 3 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.07% | 1.30M | 0.58% |
| 4 | Avantis Emerging Markets Value ETF AVES | 0.05% | 683.1K | 0.36% |
| 5 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.03% | 38.8K | 0.42% |
| 6 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.03% | 19.1K | 0.74% |
| 7 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.02% | 81.0K | 0.72% |
| 8 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 58.0K | 0.74% |
| 9 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.02% | 97.8K | 0.55% |
| 10 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.01% | 30.7K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Wei Wu | Executive Chairman of the Board | 1M | male |
| Guoqing Xiao | Executive Deputy Chairman | 513.8K | male |
| Chaosheng Mao | Joint Company Secretary | — | male |
| Sau Mei Ng ACIS FCIS | Joint Company Secretary | — | female |
| Siu Kei Au Yeung | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0667.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
